Spheroid-Induced Epithelial-Mesenchymal Transition Provokes Global Alterations of Breast Cancer Lipidome: A Multi-Layered Omics Analysis

• Published in: Frontiers in oncology 2019-03, Vol.9, p.145-145
• Main Authors: Kang, Yun Pyo, Yoon, Jung-Ho, Long, Nguyen Phuoc, Koo, Gi-Bang, Noh, Hyun-Jin, Oh, Seung-Jae, Lee, Sae Bom, Kim, Hyung Min, Hong, Ji Yeon, Lee, Won Jun, Lee, Seul Ji, Hong, Soon-Sun, Kwon, Sung Won, Kim, You-Sun
• Format: Article
• Language: English
• Subjects: breast cancer; ELOVL2; epithelial-mesenchymal transition; fatty acid metabolism; lipidomics; Oncology; transcriptomics
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2019.00145

Metabolic rewiring has been recognized as an important feature to the progression of cancer. However, the essential components and functions of lipid metabolic networks in breast cancer progression are not fully understood. In this study, we investigated the roles of altered lipid metabolism in the malignant phenotype of breast cancer. Using a spheroid-induced epithelial-mesenchymal transition (EMT) model, we conducted multi-layered lipidomic and transcriptomic analysis to comprehensively describe the rewiring of the breast cancer lipidome during the malignant transformation. A tremendous homeostatic disturbance of various complex lipid species including ceramide, sphingomyelin, ether-linked phosphatidylcholines, and ether-linked phosphatidylethanolamine was found in the mesenchymal state of cancer cells. Noticeably, polyunsaturated fatty acids composition in spheroid cells was significantly decreased, accordingly with the gene expression patterns observed in the transcriptomic analysis of associated regulators. For instance, the up-regulation of , and and the down-regulation of , and were found among other lipid metabolic regulators. Significantly, the ratio of C22:6n3 (docosahexaenoic acid, DHA) to C22:5n3 was dramatically reduced in spheroid cells analogously to the down-regulation of . Following mechanistic study confirmed the up-regulation of and down-regulation of , and in the spheroid cells. Furthermore, the depletion of induced metastatic characteristics in breast cancer cells via the SREBPs axis. A subsequent large-scale analysis using 51 breast cancer cell lines demonstrated the reduced expression of in basal-like phenotypes. Breast cancer patients with low expression exhibited poor prognoses (HR = 0.76, CI = 0.67-0.86). Collectively, expression is associated with the malignant phenotypes and appear to be a novel prognostic biomarker in breast cancer. In conclusion, the present study demonstrates that there is a global alteration of the lipid composition during EMT and suggests the down-regulation of induces lipid metabolism reprogramming in breast cancer and contributes to their malignant phenotypes.